Detection of prostate cancer in an ethnically diverse, disadvantaged population with multiple prostate specific antigen measurements before biopsy

A. Ari Hakimi, Ilir Agalliu, Gloria Y. Ho, Reza Ghavamian, Chaghong Yu, Michael W. Kattan, Farhang Rabbani

Research output: Contribution to journalArticle

Abstract

Purpose: We assessed the predictive effect of prostate specific antigen velocity for men with a minimum of 3 pre-biopsy prostate specific antigen measurements in a racially diverse population. Materials and Methods: We identified 795 patients who underwent 3 or more prostate specific antigen tests before prostate biopsy. Prostate specific antigen velocity was calculated by linear regression and used to assess associations with the risk of prostate cancer overall and of high grade prostate cancer (Gleason score 710). We created ROC curves and determined the AUC for several models, including only prostate specific antigen velocity or the last prostate specific antigen measurement before biopsy, to predict prostate cancer and high grade prostate cancer. Results: The risk of prostate cancer and high grade prostate cancer increased linearly with increasing prostate specific antigen velocity quartiles (each p trend <0.001). Older patients were more likely to be diagnosed with prostate cancer, given the same prostate specific antigen velocity. In black and Hispanic patients there were strong linear associations between increasing prostate specific antigen velocity and the risk of prostate cancer overall and high grade prostate cancer. ROC curves incorporating prostate specific antigen velocity to predict prostate cancer and high grade prostate cancer varied significantly by race. The AUC of models in black and Hispanic patients was significantly higher than in white patients (0.62 and 0.64, respectively, vs 0.47, p = 0.03). Conclusions: Prostate specific antigen velocity is a significant predictor of prostate cancer and high grade prostate cancer in men with 3 or more prostate specific antigen tests before prostate biopsy. Black and Hispanic patients appear to be at increased risk for prostate cancer at higher prostate specific antigen velocity, as are men older than 60 years. Further studies should confirm these results and create age and race specific guidelines to assess prostate specific antigen velocity.

Original languageEnglish (US)
Pages (from-to)1234-1240
Number of pages7
JournalJournal of Urology
Volume187
Issue number4
DOIs
StatePublished - Apr 2012

Fingerprint

Vulnerable Populations
Prostate-Specific Antigen
Prostatic Neoplasms
Biopsy
Population
Hispanic Americans
ROC Curve
Area Under Curve
Prostate
Neoplasm Grading
Linear Models

Keywords

  • African Americans
  • Hispanic Americans
  • prostate
  • prostate-specific antigen
  • prostatic neoplasms

ASJC Scopus subject areas

  • Urology

Cite this

Detection of prostate cancer in an ethnically diverse, disadvantaged population with multiple prostate specific antigen measurements before biopsy. / Hakimi, A. Ari; Agalliu, Ilir; Ho, Gloria Y.; Ghavamian, Reza; Yu, Chaghong; Kattan, Michael W.; Rabbani, Farhang.

In: Journal of Urology, Vol. 187, No. 4, 04.2012, p. 1234-1240.

Research output: Contribution to journalArticle

Hakimi, A. Ari ; Agalliu, Ilir ; Ho, Gloria Y. ; Ghavamian, Reza ; Yu, Chaghong ; Kattan, Michael W. ; Rabbani, Farhang. / Detection of prostate cancer in an ethnically diverse, disadvantaged population with multiple prostate specific antigen measurements before biopsy. In: Journal of Urology. 2012 ; Vol. 187, No. 4. pp. 1234-1240.
@article{776faa6d6fd2444e85269bdf48685280,
title = "Detection of prostate cancer in an ethnically diverse, disadvantaged population with multiple prostate specific antigen measurements before biopsy",
abstract = "Purpose: We assessed the predictive effect of prostate specific antigen velocity for men with a minimum of 3 pre-biopsy prostate specific antigen measurements in a racially diverse population. Materials and Methods: We identified 795 patients who underwent 3 or more prostate specific antigen tests before prostate biopsy. Prostate specific antigen velocity was calculated by linear regression and used to assess associations with the risk of prostate cancer overall and of high grade prostate cancer (Gleason score 710). We created ROC curves and determined the AUC for several models, including only prostate specific antigen velocity or the last prostate specific antigen measurement before biopsy, to predict prostate cancer and high grade prostate cancer. Results: The risk of prostate cancer and high grade prostate cancer increased linearly with increasing prostate specific antigen velocity quartiles (each p trend <0.001). Older patients were more likely to be diagnosed with prostate cancer, given the same prostate specific antigen velocity. In black and Hispanic patients there were strong linear associations between increasing prostate specific antigen velocity and the risk of prostate cancer overall and high grade prostate cancer. ROC curves incorporating prostate specific antigen velocity to predict prostate cancer and high grade prostate cancer varied significantly by race. The AUC of models in black and Hispanic patients was significantly higher than in white patients (0.62 and 0.64, respectively, vs 0.47, p = 0.03). Conclusions: Prostate specific antigen velocity is a significant predictor of prostate cancer and high grade prostate cancer in men with 3 or more prostate specific antigen tests before prostate biopsy. Black and Hispanic patients appear to be at increased risk for prostate cancer at higher prostate specific antigen velocity, as are men older than 60 years. Further studies should confirm these results and create age and race specific guidelines to assess prostate specific antigen velocity.",
keywords = "African Americans, Hispanic Americans, prostate, prostate-specific antigen, prostatic neoplasms",
author = "Hakimi, {A. Ari} and Ilir Agalliu and Ho, {Gloria Y.} and Reza Ghavamian and Chaghong Yu and Kattan, {Michael W.} and Farhang Rabbani",
year = "2012",
month = "4",
doi = "10.1016/j.juro.2011.11.090",
language = "English (US)",
volume = "187",
pages = "1234--1240",
journal = "Journal of Urology",
issn = "0022-5347",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Detection of prostate cancer in an ethnically diverse, disadvantaged population with multiple prostate specific antigen measurements before biopsy

AU - Hakimi, A. Ari

AU - Agalliu, Ilir

AU - Ho, Gloria Y.

AU - Ghavamian, Reza

AU - Yu, Chaghong

AU - Kattan, Michael W.

AU - Rabbani, Farhang

PY - 2012/4

Y1 - 2012/4

N2 - Purpose: We assessed the predictive effect of prostate specific antigen velocity for men with a minimum of 3 pre-biopsy prostate specific antigen measurements in a racially diverse population. Materials and Methods: We identified 795 patients who underwent 3 or more prostate specific antigen tests before prostate biopsy. Prostate specific antigen velocity was calculated by linear regression and used to assess associations with the risk of prostate cancer overall and of high grade prostate cancer (Gleason score 710). We created ROC curves and determined the AUC for several models, including only prostate specific antigen velocity or the last prostate specific antigen measurement before biopsy, to predict prostate cancer and high grade prostate cancer. Results: The risk of prostate cancer and high grade prostate cancer increased linearly with increasing prostate specific antigen velocity quartiles (each p trend <0.001). Older patients were more likely to be diagnosed with prostate cancer, given the same prostate specific antigen velocity. In black and Hispanic patients there were strong linear associations between increasing prostate specific antigen velocity and the risk of prostate cancer overall and high grade prostate cancer. ROC curves incorporating prostate specific antigen velocity to predict prostate cancer and high grade prostate cancer varied significantly by race. The AUC of models in black and Hispanic patients was significantly higher than in white patients (0.62 and 0.64, respectively, vs 0.47, p = 0.03). Conclusions: Prostate specific antigen velocity is a significant predictor of prostate cancer and high grade prostate cancer in men with 3 or more prostate specific antigen tests before prostate biopsy. Black and Hispanic patients appear to be at increased risk for prostate cancer at higher prostate specific antigen velocity, as are men older than 60 years. Further studies should confirm these results and create age and race specific guidelines to assess prostate specific antigen velocity.

AB - Purpose: We assessed the predictive effect of prostate specific antigen velocity for men with a minimum of 3 pre-biopsy prostate specific antigen measurements in a racially diverse population. Materials and Methods: We identified 795 patients who underwent 3 or more prostate specific antigen tests before prostate biopsy. Prostate specific antigen velocity was calculated by linear regression and used to assess associations with the risk of prostate cancer overall and of high grade prostate cancer (Gleason score 710). We created ROC curves and determined the AUC for several models, including only prostate specific antigen velocity or the last prostate specific antigen measurement before biopsy, to predict prostate cancer and high grade prostate cancer. Results: The risk of prostate cancer and high grade prostate cancer increased linearly with increasing prostate specific antigen velocity quartiles (each p trend <0.001). Older patients were more likely to be diagnosed with prostate cancer, given the same prostate specific antigen velocity. In black and Hispanic patients there were strong linear associations between increasing prostate specific antigen velocity and the risk of prostate cancer overall and high grade prostate cancer. ROC curves incorporating prostate specific antigen velocity to predict prostate cancer and high grade prostate cancer varied significantly by race. The AUC of models in black and Hispanic patients was significantly higher than in white patients (0.62 and 0.64, respectively, vs 0.47, p = 0.03). Conclusions: Prostate specific antigen velocity is a significant predictor of prostate cancer and high grade prostate cancer in men with 3 or more prostate specific antigen tests before prostate biopsy. Black and Hispanic patients appear to be at increased risk for prostate cancer at higher prostate specific antigen velocity, as are men older than 60 years. Further studies should confirm these results and create age and race specific guidelines to assess prostate specific antigen velocity.

KW - African Americans

KW - Hispanic Americans

KW - prostate

KW - prostate-specific antigen

KW - prostatic neoplasms

UR - http://www.scopus.com/inward/record.url?scp=84858702004&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84858702004&partnerID=8YFLogxK

U2 - 10.1016/j.juro.2011.11.090

DO - 10.1016/j.juro.2011.11.090

M3 - Article

C2 - 22335862

AN - SCOPUS:84858702004

VL - 187

SP - 1234

EP - 1240

JO - Journal of Urology

JF - Journal of Urology

SN - 0022-5347

IS - 4

ER -